Steward Partners Investment Advisory’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49K Sell
460
-241
-34% -$29.2K ﹤0.01% 2958
2026
Q1
$115K Sell
701
-8
-1% -$1.23K ﹤0.01% 2301
2025
Q4
$123K Buy
709
+21
+3% +$3.83K ﹤0.01% 2176
2025
Q3
$99.1K Buy
688
+74
+12% +$9.06K ﹤0.01% 2238
2025
Q2
$61.8K Sell
614
-139
-18% -$10.6K ﹤0.01% 2372
2025
Q1
$57.4K Buy
753
+340
+82% +$26K ﹤0.01% 2312
2024
Q4
$28.5K Buy
413
+163
+65% +$11.7K ﹤0.01% 2613
2024
Q3
$18.3K Buy
+250
New +$18.4K ﹤0.01% 2697
2021
Q2
– Sell
-1
Closed -$34 – 7244
2021
Q1
$34 Buy
+1
New +$38 ﹤0.01% 3401

Other funds holding INSM

Steward Partners Investment Advisory's INSM Position: Q2 2026 in Review

Steward Partners Investment Advisory reduced its Insmed (INSM) stake by 34% in Q2 2026, selling an estimated $29.2K and leaving 460 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #2958.

Steward Partners Investment Advisory first reported a position in INSM in Q1 2021 and has held it in 9 quarters since. The position peaked at $123K in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Steward Partners Investment Advisory held 460 shares of Insmed worth $49K as of Q2 2026.
  • Steward Partners Investment Advisory sold 241 Insmed shares in Q2 2026, an estimated $29.2K.
  • Insmed made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2958 holding.
  • Steward Partners Investment Advisory first reported a position in Insmed in Q1 2021 and has held it in 9 quarters since.
  • Steward Partners Investment Advisory's Insmed position peaked at $123K in Q4 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.